TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 4 | 4 | -15 | -19 | -50 | -44 | -20 |
| P | %wins | 100 | 33 | 0 | 0 | 0 | 0 | 22 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/07 09:11 | 11/12/07 | ASTM | Aastrom Biosciences Inc | MI | Health | Biolab | Commercial Physical & Biologi | Sims Nelson M | MI | D | P | 9 | 0.9000 | 0 | 10 | 182 | 16 | I | -55 | -36 | -35 | -17 | -21 | -15 | -8 | 1 | 0 | -10 | -17 | -28 | -58 | -32 | |
10/12/04 13:30 | 10/8/04 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sims Nelson M | MD | O | P,CEO | P | 38 | 3.28 | 1 | 12 | 85 | 25 | D | -9 | -60 | -44 | -36 | -6 | 1 | 3 | 3 | 8 | 23 | -4 | -6 | -52 | -22 |
7/27/04 15:42 | 7/26/04 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sims Nelson M | MD | O | P,CEO | P | 61 | 4.55 | 1 | 14 | New | 14 | D | 80 | -17 | -23 | -15 | -7 | -10 | -6 | 11 | 5 | -2 | -25 | -24 | -39 | -78 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |